Eversept Partners, LP

Position in IFRX — InflaRx N.V.

CIK 1697013 NEW YORK, NY

Position in IFRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,572,164

-$202,721 QoQ

Shares Held

1,758,573

+0.1% QoQ

Ownership

1.19%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Eversept Partners, LP holds $674,697,695 across 57 Biotechnology names. IFRX ranks #44 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	934,423	$104,048,001
2	VERA	Vera Therapeutics, Inc.	2,173,286	$87,431,295
3	SNDX	Syndax Pharmaceuticals Inc	2,885,622	$67,408,129
4	CLDX	Celldex Therapeutics, Inc.	1,788,016	$56,715,867
5	PCVX	Vaxcyte, Inc.	924,193	$53,704,855
6	IONS	Ionis Pharmaceuticals Inc	632,100	$47,464,389
7	GERN	Geron Corp	18,834,883	$28,063,975
8	TVTX	Travere Therapeutics, Inc.	542,610	$16,120,943

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,572,164	1,758,573	+0.1%	Shares	Sole	2026-05-15
2025-12-31	$1,774,885	1,757,312	+1.5%	Shares	Sole	2026-02-17
2025-09-30	$2,319,050	1,730,635	+5.5%	Shares	Sole	2025-11-14
2025-06-30	$1,295,939	1,640,430	-2.1%	Shares	Sole	2025-08-14
2025-03-31	$1,709,497	1,675,978	+240.3%	Shares	Sole	2025-05-15
2024-12-31	$1,216,356	492,452	-69.6%	Shares	Sole	2025-02-14
2024-09-30	$2,481,334	1,621,787	+3.5%	Shares	Sole	2024-11-14
2024-06-30	$2,726,458	1,566,930	+20.1%	Shares	Sole	2024-08-14
2024-03-31	$2,009,915	1,305,140	0.0%	Shares	Sole	2024-05-15
2023-12-31	$2,127,378	1,305,140	-24.9%	Shares	Sole	2024-02-14
2023-09-30	$5,177,881	1,737,544	-9.3%	Shares	Sole	2023-11-14
2023-06-30	$8,541,403	1,915,113	+612.9%	Shares	Sole	2023-11-08
2021-03-31	$1,047,672	268,634	+37.4%	Shares	Sole	2021-05-13
2020-03-31	$746,764	195,488	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.